Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Clinical trial NCT03886493 · TERMINATED
Trial details
- NCT number
- NCT03886493
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-28
- Primary completion
- 2020-10-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.